Abstract
Indirect chiral ligand exchange chromatography (ICLEC) was facilitated by substituting chiral ligands from the bidentate Cu(II) complex via racemic analytes in reaction vial. In-vial ligand exchange does not require the potentially harmful Cu(II)-containing mobile phase for HPLC separation, as it facilitates better pH control for improved complexation of enantiomers with the chiral Cu(II)-ligand complex. Resulting Cu(II)-analyte-ligand complexes have higher stability constants and show better chromatographic resolution than conventional (CLEC). The new technique also eliminates background noise, a problem with conventional CLEC due to higher concentrations of Cu-containing selector due to the Cu-free mobile phase. The new technique was found successful in determining enantiomeric purity of drugs in pharmaceutical formulations. The technique can be regarded as a novel surrogate for conventional CLEC and has the potential for biological and pharmaceutical applications.
Original language | English |
---|---|
Pages (from-to) | 50130-50136 |
Number of pages | 7 |
Journal | RSC Advances |
Volume | 4 |
Issue number | 91 |
DOIs | |
State | Published - 2014 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© The Royal Society of Chemistry 2014.